Original Research

Clinical, Original Research
Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan
Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD
Stakeholder Perspective
Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence
F. Randy Vogenberg, PhD, FASHP
Read More
Clinical, Original Research
Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias-Rodriguez, MD; Kamala Nola, PharmD, MS
Read More
Business, Original Research
Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption
Cori Gray, PharmD; James T. Kenney, RPh, MBA
Stakeholder Perspective
Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods
Gary Branning, MBA
Read More
Business, Original Research
The Economic Implications of Hyperkalemia in a Medicaid Managed Care Population
Nihar R. Desai, MD, MPH; Pamala Reed, DrPH, MPH; Paula J. Alvarez, RPh, MBA, MPH; Jeanene Fogli, PhD, RD; Steven D. Woods, PharmD; Mary Kay Owens, RPh, CPh
Stakeholder Perspective
The Impact of Quality Care on a Medicaid Population with Hyperkalemia
Byron C. Scott, MD, MBA
Read More
Business, Original Research
Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia
David Campbell, PharmD, MS; Marlo Blazer, PharmD, BCOP; Lisa Bloudek, PharmD, MS; John Brokars, MS; Dinara Makenbaeva, MD, MBA
Stakeholder Perspective
The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs
James T. Kenney, RPh, MBA
Read More
Business, Original Research
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
Michael C. Runken, PharmD; Joshua M. Noone, PhD; Christopher M. Blanchette, PhD, MBA; Emily Zacherle, MS; Reuben Howden, PhD
Stakeholder Perspective
Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?
Gary M. Owens, MD
Read More
Business, Original Research
Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer
Krishna Tangirala, MPH; Sreevalsa Appukkuttan, MPH, MBBS; Stacey Simmons, MD
Read More
Clinical, Original Research
Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System
Anne Misher, PharmD, BCACP, BC-ADM, CDE; Jessica Brown, PharmD; Christina Maguire, PharmD; Alix P. Schnibben, PharmD, BCACP, CTTS
Stakeholder Perspective
Benefits of Employer-Sponsored Wellness Programs for Chronic Diseases
F. Randy Vogenberg, RPh, PhD, FASHP
Read More
Clinical, Original Research
Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus
Pragya Rai, MS; Nilanjana Dwibedi, PhD; Mazhgan Rowneki, MPH; Drew A. Helmer, MD, MS; Usha Sambamoorthi, PhD
Stakeholder Perspective
Impact of DPP-4 Inhibitors on Joint Pain in Older Veterans with Diabetes
Priya Nileshwar, DO; Quang Nguyen, DO, FACE, FTOS
Read More
Business, Original Research
Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing
Joshua A. Roth, PhD, MHA; Theo deVos, PhD; Scott D. Ramsey, MD, PhD
Read More
Page 4 of 11
Results 31 - 40 of 107
SUBSCRIBE
© Amplity Health. All rights reserved.